Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02309177
What this trial is testing

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsPancreatic Neoplasms
Celgene 114
Large-scale testing (Phase 3)UnknownNCT04942275
What this trial is testing

Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy

Who this might be right for
SBRTNon-small Cell Lung CancerLung Metastasis
University Hospital, Brest 60
Not applicableLooking for participantsNCT06109454
What this trial is testing

Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery

Who this might be right for
Non-small Cell Lung Cancer
Liaoning Cancer Hospital & Institute 240
Testing effectiveness (Phase 2)Ended earlyNCT02488694
What this trial is testing

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer With Somatic EGFR Mutations
AIO-Studien-gGmbH 4
Testing effectiveness (Phase 2)Ended earlyNCT01578551
What this trial is testing

Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.

Who this might be right for
Carcinoma, Non-Small-Cell LungLung Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT00050830
What this trial is testing

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasms
Pfizer 163
Not applicableUnknownNCT01344005
What this trial is testing

Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years

Who this might be right for
Lung CancerTobacco Use Disorder
Wales Cancer Trials Unit 386
Early research (Phase 1)Study completedNCT07620951
What this trial is testing

Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China

Who this might be right for
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd. 6
Not applicableStudy completedNCT03569072
What this trial is testing

High Intensity Functional Image Guided Vmat Lung Evasion

Who this might be right for
Non Small Cell Lung Cancer Stage III
Peter MacCallum Cancer Centre, Australia 19
Large-scale testing (Phase 3)UnknownNCT01560195
What this trial is testing

Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

Who this might be right for
NSCLCNeutropeniaFebrile Neutropenia
Jiangsu HengRui Medicine Co., Ltd. 150
Not applicableWithdrawnNCT04085081
What this trial is testing

Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers

Who this might be right for
CaregiverLobectomy PatientLung Carcinoid Tumor+1 more
City of Hope Medical Center
Not applicableStudy completedNCT03645330
What this trial is testing

Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

Who this might be right for
Non-small-Cell Lung Cancer
Chugai Pharmaceutical 1,026
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Not applicableUnknownNCT05716672
What this trial is testing

Impact of Lazertinib Dose Modification on Effectiveness and Safety

Who this might be right for
Non-small Cell Lung Cancer
Pusan National University Hospital 200
Early research (Phase 1)Study completedNCT00569712
What this trial is testing

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol

Who this might be right for
Lung CancerPrecancerous Condition
British Columbia Cancer Agency 30
Not applicableStudy completedNCT02805530
What this trial is testing

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell LungSynchronous Neoplasms
Instituto Nacional de Cancerologia de Mexico 36
Not applicableUnknownNCT05010330
What this trial is testing

Identify Prognostic Biomarkers of Lung Cancer

Who this might be right for
Lung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma+1 more
RenJi Hospital 500
Testing effectiveness (Phase 2)UnknownNCT04455594
What this trial is testing

Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Stage IIIA
The First Affiliated Hospital of Guangzhou Medical University 168
Testing effectiveness (Phase 2)Study completedNCT02576431
What this trial is testing

Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 215
Large-scale testing (Phase 3)Active Not RecruitingNCT05502237
What this trial is testing

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Gilead Sciences 1,021
Next Page